Is RUBY or XYLD a better dividend investment in 2026?

RUBY currently yields 3508.77% with a 5% 5-year dividend growth rate. XYLD yields 11.20% with 0.5% growth. The better choice depends on your goal: RUBY offers higher current income.

What is the dividend yield difference between RUBY and XYLD?

RUBY has a forward dividend yield of 3508.77% ($2.00/share annually). XYLD yields 11.20% ($4.30/share annually). The yield gap is 3497.57 percentage points.

Home › Compare › RUBY vs XYLD

RUBY vs XYLD: Dividend Comparison 2026

RUBY yields 3508.77% · XYLD yields 11.20%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RUBY wins by $2034141393542.06M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RUBY

● Live price

3508.77%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2034141393542.08M

Annual income

$1,926,153,862,282,748,700.00

Full RUBY calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

11.20%

Share price

$38.36

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$3,351.03

Full XYLD calculator →

Portfolio growth — RUBY vs XYLD

📍 RUBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RUBY	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RUBY + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RUBY pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBY

Annual income on $10K today (after 15% tax)

$298,245.61/yr

After 10yr DRIP, annual income (after tax)

$1,637,230,782,940,336,400.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$952.37/yr

After 10yr DRIP, annual income (after tax)

$2,848.38/yr

At 15% tax rate, RUBY beats the other by $1,637,230,782,940,333,600.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBY + XYLD for your $10,000?

RUBY: 50%XYLD: 50%

100% XYLD50/50100% RUBY

Portfolio after 10yr

$1017070696771.05M

Annual income

$963,076,931,141,376,000.00/yr

Blended yield

94.69%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBY buys

XYLD buys

No recent congressional trades found for RUBY or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRUBYXYLD

Forward yield	3508.77% ✓	11.20%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2034141393542.08M ✓	$25.9K
Annual income after 10y	$1,926,153,862,282,748,700.00 ✓	$3,351.03
Total dividends collected	$2026733119198.63M ✓	$20.2K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: RUBY vs XYLD ($10,000, DRIP)

Year	RUBY Portfolio	RUBY Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$361,577	$350,877.19	$10,840	$1,120.44	+$350.7K → RUBY
2	$12,243,821	$11,856,933.69	$11,786	$1,249.59	+$12.23M → RUBY
3	$388,336,948	$375,236,059.53	$12,854	$1,397.78	+$388.32M → RUBY
4	$11,538,279,357	$11,122,758,822.00	$14,063	$1,568.33	+$11538.27M → RUBY
5	$321,205,540,543	$308,859,581,631.20	$15,434	$1,765.19	+$321205.53M → RUBY
6	$8,379,307,864,544	$8,035,617,936,162.96	$16,995	$1,993.14	+$8379307.85M → RUBY
7	$204,877,671,222,196	$195,911,811,807,134.25	$18,777	$2,257.95	+$204877671.20M → RUBY
8	$4,695,974,086,156,479	$4,476,754,977,948,728.50	$20,818	$2,566.58	+$4695974086.14M → RUBY
9	$100,922,926,410,592,910	$95,898,234,138,405,470.00	$23,163	$2,927.50	+$100922926410.57M → RUBY
10	$2,034,141,393,542,082,800	$1,926,153,862,282,748,700.00	$25,865	$3,351.03	+$2034141393542.06M → RUBY

RUBY vs XYLD: Complete Analysis 2026

RUBY — Stock

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Full RUBY Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this RUBY vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBY vs SCHD RUBY vs JEPI RUBY vs O RUBY vs KO RUBY vs MAIN RUBY vs QYLD RUBY vs JEPQ RUBY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.